Orchestra BioMed Holdings, Inc. financial data

Symbol
OBIO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
150 Union Square Drive, New Hope, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Health Sciences Acquisitions Corp 2 (to 1/26/2023)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 574 % -17.4%
Quick Ratio 1.08 % -16.3%
Debt-to-equity 66.2 %
Return On Equity -107 % -86.7%
Return On Assets -70.9 % -82.4%
Operating Margin -2.27K % -67.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38M shares +6.35%
Common Stock, Shares, Outstanding 37.9M shares +6.15%
Entity Public Float 123M USD -22.7%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 37.6M shares +6.75%
Weighted Average Number of Shares Outstanding, Diluted 37.6M shares +6.75%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.65M USD -26.5%
Cost of Revenue 193K USD +0.52%
Research and Development Expense 40.3M USD +22.8%
General and Administrative Expense 2.96M USD +977%
Costs and Expenses 62.8M USD +19.6%
Operating Income (Loss) -60.1M USD -23%
Net Income (Loss) Attributable to Parent -57.7M USD -25.3%
Earnings Per Share, Basic -1.59 USD/shares -8.16%
Earnings Per Share, Diluted -1.59 USD/shares -8.16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.6M USD +34.2%
Marketable Securities, Current 41.3M USD -53.8%
Accounts Receivable, after Allowance for Credit Loss, Current 115K USD +33.7%
Inventory, Net 234K USD +70.8%
Assets, Current 68.6M USD -37.8%
Property, Plant and Equipment, Net 1.25M USD -7.45%
Operating Lease, Right-of-Use Asset 1.71M USD 0%
Assets 75.3M USD -35.3%
Accounts Payable, Current 4.72M USD +49.9%
Employee-related Liabilities, Current 2.63M USD +2.3%
Accrued Liabilities, Current 7.03M USD +63.5%
Liabilities, Current 16.2M USD -24.5%
Deferred Income Tax Liabilities, Net 508K USD -20.3%
Operating Lease, Liability, Noncurrent 1.44M USD +29.2%
Other Liabilities, Noncurrent 266K USD
Liabilities 29.1M USD -20.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 98K USD
Retained Earnings (Accumulated Deficit) -294M USD -24.4%
Stockholders' Equity Attributable to Parent 99.8M USD +127788%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 46.2M USD -42%
Liabilities and Equity 75.3M USD -35.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD +8.81%
Net Cash Provided by (Used in) Financing Activities 56.8M USD +129%
Net Cash Provided by (Used in) Investing Activities 5.86M USD
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 37.9M shares +6.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.24M USD -564%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 25.6M USD +34.2%
Deferred Tax Assets, Valuation Allowance 60.1M USD +29.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.5 pure
Deferred Tax Assets, Gross 60.6M USD +28.8%
Operating Lease, Liability 1.84M USD -1.4%
Depreciation 297K USD +4.21%
Payments to Acquire Property, Plant, and Equipment 8K USD -77.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -57.5M USD -24.7%
Lessee, Operating Lease, Liability, to be Paid 2.18M USD +4.81%
Property, Plant and Equipment, Gross 2.47M USD +5.32%
Operating Lease, Liability, Current 395K USD -47.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 682K USD +93.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 551K USD -24.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +64%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 341K USD +58.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 643K USD +82.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 159K USD -54.8%
Operating Lease, Payments 228K USD +11.2%
Additional Paid in Capital 340M USD +7.62%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 74K USD +4.23%
Deferred Tax Assets, Net of Valuation Allowance 508K USD -20.3%
Operating Leases, Future Minimum Payments Due 2.49M USD
Interest Expense 351K USD +48.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%